bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received U.S. Food and Drug Administration approval of its INSTI HIV Antibody Test for use in detecting antibodies to HIV type 2 (HIV-2).
from The Medical News http://ift.tt/17ugSXt
from The Medical News http://ift.tt/17ugSXt
No comments:
Post a Comment